期刊文献+

儿童自身免疫性甲状腺炎患者血清趋化因子CXCL10及其受体CXCR3的变化及其临床意义 被引量:3

原文传递
导出
摘要 目的 探讨血清趋化因子CXCL10及其受体CXCR3在儿童自身免疫性甲状腺炎(HT)患者中的水平变化及其临床意义.方法 采用ELISA检测42例儿童自身免疫性甲状腺炎患者血清CXCL10和CXCR3水平,并以42例健康体检儿童作为对照.结果 HT组患者血清CXCL10和CXCR3水平明显高于对照组(t=15.509、23.751,均P<0.05),且血清CXCL10和CXCR3水平在儿童HT发病初期及未缓解期高于缓解期(t=17.188、20.048、16.427、20.369,均P<0.05);血清CXCL10与CXCR3表达呈高度正相关(r=0.772,P<0.01).结论 CXCL10和CXCR3在儿童自身免疫性甲状腺炎的过度表达可能与其发生和发展有关,在儿童HT病程中存在着动态变化,可以作为预测儿章HT的疾病活动性的指标之一.
出处 《中国基层医药》 CAS 2014年第2期259-261,共3页 Chinese Journal of Primary Medicine and Pharmacy
  • 相关文献

参考文献7

  • 1胡天一,刘戈力,杨箐岩,马咸成,刘国玉.趋化因子CXCL10在儿童自身免疫性甲状腺炎中的作用和变化[J].天津医科大学学报,2010,16(1):117-119. 被引量:2
  • 2Liu C, Papewalis C, Domberg J, et al. Chemokines and autoimmune thyroid diseases[J]. Horm Metab Res,2008,40(6) :361-368.
  • 3Antonelli A, Ferri C, Fallahi P, et al. CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis-a longitudinal study[ Jl. Rheumatology(Oxford) ,2008,47( 1 ) :45-49.
  • 4Garca-L6pez MA, Sancho D, S/mchez-Madrid F, et al. Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-IO and Mig and attract CXCR3 + lymphocytes[ J]. J Clin EndocrinolMetab,2001,86(10) :5008-5016.
  • 5Cakir M, Levendoglu F, Kiyici A, et al. Serum CXCL10 levels and neuromuscular manifestations in patients with autoimmune thyroid diseases[J]. Autoimmunity,2011,44(6) :496-503.
  • 6Corona G, Biagini C, Rotondi M, et al. Correlation between, clini- cal, biochemical, color Doppler Ultrasound thyroid parameters, and CXCL-10 in autoimmune thyroid diseases [ J ]. Endoer J,2008,55 (2) :345-350.
  • 7Kemp EH, Metcalfe RA, Smith KA, et al. Detection and localization of ehemokine gene expression in autoimmune thyroid disease [ J ], Clin Endoerinol (Oxf) ,2003,59 ( 2 ) :207-213.

二级参考文献9

  • 1Rotondi M, Chiovato L, Romagnani S,et al. Role of chemokines in endocrine autoimmune diseases[J]. Endocrine Reviews,2007,28(5):492.
  • 2Kemp EH, Metcalfe RA. Smith KA,et al. Detection and localization of chemokine gene expression in autoimmune thyroid disease [J]. Clin Endocrinol 2003,59(2):207.
  • 3Romagnani P, Beltrame C, Annunziato F, et al. Role for interactions between IP-10/Mig and their receptor (CXCR3) in proliferative glomerulonephritis[J]. Am Soc Nephrol,1999,10(2):2518.
  • 4Garcia-Lopez MA .Sanchez-Madrid F,Rodriguez-Frade JM ,et al. CXCR3 chemokine receptor distribution in normal and inflamed tissues: expression on activated lymph~ytes, endothelial cells, and dendritic cells[J]. Lab Invest,2001,81 (3) :409.
  • 5Diez JJ, Hernanz A.Medina S, et al.Serum concentrations of tumour necrosis factor-a (TNF-a) and soluble TNF-a receptor p55 in patients with hypothyroidism and hyperthyroidism before and after normalization of thyroid function [J]. J Clin Endocrinol , 2002,57( 1 ):515.
  • 6Antonelli A, Rotondi M, Fallahi P,et al. High levels of circulating CXC chemokine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidism [J].Clin Endocrinol Metab, 2004,89 (11):5496.
  • 7Corona G, Biagini C,Rotondi M, el al. Correlation between, clinical, biochemical, color Doppler ultrasound thyroid parameters, and CXCL-10 in autoimmune thyroid diseases [J]. Endocr J,2008,55 (2):345.
  • 8Antonelli A, Fallahi P,Rotondi M, et al.Increased serum CXCLIO in Graves' disease or autoimmune thyroiditis is not associated with hyperor hypothyroidism per se,but is specifically sustained by the autoimmune, inflammatory process[J]. Eur J Endocrinol,2006,154 (5):651.
  • 9Domberg J, Liu C, Papewalis C,et al. Circulating chemokines in patients with autoimmune thyroid diseases [J]. Horm Metab Res, 2008,40(6):416.

共引文献1

同被引文献32

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部